While all subcutaneous injections enter the body through this process, the way they work once absorbed varies by immunotherapy type. The Food and Drug Administration (FDA) has approved several ...

Subcutaneous injectable drugs can be a much quicker process. However, some observation is still typically required after injections, and the actual difference in treatment time may not be all that ...

One day after a subcutaneous injection into the left ... will resolve and that it is not related to the disease process. The proper injection technique should be reviewed, and patients should ...

The Vyvgart Hytrulo prefilled syringe is approved as a 20- to 30-second subcutaneous injection administered by a patient, ...

Bristol Myers Squibb's Opdivo has been approved in a subcutaneous injection formulation by the FDA, making treatment easier for patients and potentially adding years to the product's patent life.

DelveInsight's "HEMLIBRA Market Size, Forecast, and Market Insight Report" highlights the details around HEMLIBRA, a bispecific factor IXa- and factor X-directed antibody indicated for routine ...

Argenx’s VYVGART Hytrulo prefilled syringe for self-injection has received FDA approval for the treatment of adult patients ...

Shelf-stable vaccine patch maker Vaxess Technologies announced today that it received an additional $9 million in funding.

The FDA has approved a subcutaneous self-injectable for adults with generalized myasthenia gravis who are anti-acetylcholine ...

The Vyvgart Hytrulo prefilled syringe is approved as a 20- to 30-second subcutaneous injection administered by a patient, caregiver, or health care professional.